Dsm-firmenich, innovators in nutrition, health, and beauty, has announced a groundbreaking collaboration with ExoLab Italia, an innovative start-up specializing in plant-derived exosomal technologies from Italian organic fruits and vegetables.
Leading the Personal Care industry in its commitment to continuous innovation, the strategic partnership between dsm-firmenich Perfumery & Beauty and ExoLab Italia marks a pivotal moment in its broader strategy for innovation and sustained growth. Through this remarkable collaboration, dsm-firmenich becomes a pioneer in bringing the innovative, plant-derived exosomes technology to the global skincare market.
Exosomes are extracellular vesicles naturally released by cells in all living organisms. They serve as a natural delivery system for molecules produced by cells and facilitate intercellular communication. Plant-derived exosomes offer a multitude of benefits for personal care and beauty products and, ultimately, for skin health. They are packed with a powerful blend of antioxidants, vitamins, proteins, lipids, and messenger molecules that work in concert to enhance skin health and combat signs of aging. By delivering these highly bioavailable active ingredients, plant-derived exosomes provide a natural and effective way to achieve youthful, radiant-looking skin.
“I am delighted to welcome ExoLab Italia as a new partner to dsm-firmenich. Through this partnership with this pioneer in exosome treatment, we reaffirm our commitment to science as a central element to our innovation and product superiority,” said Emmanuel Butstraen, President Perfumery & Beauty. “We are thrilled to embark on this journey with ExoLab Italia. We truly believe that, together, we have the power to revolutionize the skincare market,” said Parand Salmassinia, President of Personal Care, Perfumery & Beauty, at dsm-firmenich. “This collaboration aligns perfectly with our commitment to providing our customers with the highest quality products that meet the growing demand for natural, effective and sustainable ingredients in the skincare market.”
ExoLab Italia, known for its expertise in exosomal technologies, is committed to advancing nutraceutical supplements, cosmetic products, and healthcare solutions. “By focusing on plant-derived exosomes, ExoLab Italia offers distinctive scientific proficiency in cellular health and skin recovery which, combined with dsm-firmenich’s renowned expertise in skin biology, claim substantiation, and active ingredients, offers immense potential to elevate the standards of natural and effective skincare to unprecedented heights,” shared Gabriele Campi, CEO of ExoLab Italia.
The collaboration between dsm-firmenich and ExoLab Italia represents a significant step forward in innovation within the personal care industry. By leveraging plant-derived exosomes, both companies aim to create products that truly redefine holistic beauty and wellbeing.
